Orforglipron
ATC — · 3 markets · 13 records
Orforglipron
Forms
US 6 records · 6 strengths
GB 6 records · 6 strengths
- 17.2 mgtabletFOUNDAYO
- 14.5 mgtabletFOUNDAYO
- 9 mgtabletFOUNDAYO
- 5.5 mgtabletFOUNDAYO
- 2.5 mgtabletFOUNDAYO
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名FOUNDAYO ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名FOUNDAYZ ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | MX |
|---|---|---|---|
| 17.2 mg tablet | FOUNDAYO | FOUNDAYO | |
| 14.5 mg tablet | FOUNDAYO | FOUNDAYO | |
| 9 mg tablet | FOUNDAYO | FOUNDAYO | |
| 5.5 mg tablet | FOUNDAYO | FOUNDAYO | |
| 2.5 mg tablet | FOUNDAYO | FOUNDAYO | |
| 0.8 mg tablet | FOUNDAYO | ||
tablet | FOUNDAYO | FOUNDAYZ |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.